Table 4.

Indications for the use of anticoagulation.

Anticoagulant indication	Overall N = 203	Warfarin N = 83a	DOACc N = 102a	LMWHd N = 18a
Atrial fibrillation (AF)	154 (76%)	60 (72%)	90 (88%)	4 (22%)
Pulmonary embolism (PE)/VTEb	25 (12%)	9 (11%)	9 (8.8%)	7 (39%)
Mechanical heart valve	8 (3.9%)	8 (9.6%)	0 (0%)	0 (0%)
Thrombosis prophylaxis	8 (3.9%)	3 (3.6%)	0 (0%)	5 (28%)
Other	3 (1.5%)	2 (2.4%)	1 (1.0%)	0 (0%)
Acute coronary syndrome	2 (1.0%)	0 (0%)	0 (0%)	2 (11%)
(Missing)	3 (1.5%)	1 (1.2%)	2 (2.0%)	0 (0%)

^aStatistics presented: n (%).

^bVTE – venous thromboembolism.

^cDirect oral anticoagulants.

^dLow molecular weight heparin.